Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Target site pharmacokinetics of linezolid or tigecycline in severe skin and skin structure infections with chronic fistulas
2011-000064-10Phase 4Terminated
- Sponsor
- Department of Clinical Pharmacology, Medical University of Vienna
- Start
- Feb 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of linezolid and tigecycline in skin and soft tissue infections (SSTIs) and Infected fistula (2 arms), sponsored by Department of Clinical Pharmacology, Medical University of Vienna. Started Feb 2011; status: terminated.
02
Drugs
linezolidtigecycline
03
Conditions
skin and soft tissue infections (SSTIs)Infected fistula
Beyond the preview
Go deeper on 2011-000064-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000064-10.